Ciprofloxacin MDS 250 mg Filmdragerad tablett

Země: Švédsko

Jazyk: švédština

Zdroj: Läkemedelsverket (Medical Products Agency)

Aktivní složka:

ciprofloxacinhydroklorid (monohydrat)

Dostupné s:

Medical Drug Supplies Ltd

ATC kód:

J01MA02

INN (Mezinárodní Name):

ciprofloxacin hydrochloride (monohydrate)

Dávkování:

250 mg

Léková forma:

Filmdragerad tablett

Složení:

ciprofloxacinhydroklorid (monohydrat) 291,1 mg Aktiv substans; laktosmonohydrat Hjälpämne

Třída:

Apotek

Druh předpisu:

Receptbelagt

Terapeutické oblasti:

Ciprofloxacin

Přehled produktů:

Förpacknings: Blister, 20 tabletter

Stav Autorizace:

Avregistrerad

Datum autorizace:

2015-06-17

Informace pro uživatele

Page 1 of 11
PACKAGE LEAFLET: INFORMATION FOR THE USER
CIPROFLOXACIN ACCORD 250 MG
FILM-COATED TABLETS CIPROFLOXACIN ACCORD 500 MG FILM-COATED TABLETS CIPROFLOXACIN ACCORD 750 MG
FILM-COATED TABLETS
ciprofloxacin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ciprofloxacin Accord is and what it is used for
2.
What you need to know before you take Ciprofloxacin Accord
3.
How to take Ciprofloxacin Accord
4.
Possible side effects
5.
How to store Ciprofloxacin Accord
6.
Contents of the pack and other information
1. WHAT CIPROFLOXACIN ACCORD IS AND WHAT IT IS USED FOR
Ciprofloxacin Accord contains the active substance ciprofloxacin.
Ciprofloxacin is an antibiotic
belonging to the fluoroquinolone family. Ciprofloxacin works by
killing bacteria that cause
infections. It only works with specific strains of bacteria.
ADULTS
Ciprofloxacin Accord is used in adults to treat the following
bacterial infections:
• respiratory tract infections
• long lasting or recurring ear or sinus infections
• urinary tract infections
• genital tract infections in men and women
• gastro-intestinal tract infections and intra-abdominal infections
• skin and soft tissue infections
• bone and joint infections
• to prevent infections due to the bacterium
_Neisseria meningitidis _
• anthrax inhalation exposure
Ciprofloxacin may be used in the management of patients with low white
blood cell counts
(neutropenia) who have a fever that is suspected to be due to a
bacterial infection.
If yo

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Ciprofloxacin Accord 250 mg film-coated tablets
Ciprofloxacin Accord 500 mg film-coated tablets
Ciprofloxacin Accord 750 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
250 MG:
Each film-coated tablet contains ciprofloxacin hydrochloride
equivalent to 250 mg ciprofloxacin.
Excipient(s) with known effect:
Contain 2.7 mg of Lactose monohydrate
For the full list of excipients, see section 6.1.
500 MG:
Each film-coated tablet contains ciprofloxacin hydrochloride
equivalent to 500 mg ciprofloxacin.
Excipient(s) with known effect:
Contain 5.4 mg of Lactose monohydrate
For the full list of excipients, see section 6.1.
750 MG:
Each film-coated tablet contains ciprofloxacin hydrochloride
equivalent to 750 mg Ciprofloxacin.
Excipient(s) with known effect:
Contain 8.2 mg of Lactose monohydrate
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Film-coated tablet
250 mg: White to off-white, round, approximately 10 mm in diameter
biconvex film coated tablet
with inscription ‘AM’ on one side and plain on other side.
500 mg: White to off-white, approximately 17 mm in length, 7.5 mm in
width, capsule shape,
biconvex with beveled edge, film coated tablet with inscription
‘CI’ on one side and plain on
other side.
750 mg: White to off-white, approximately 19 mm in length, 10 mm in
width, capsule shape,
biconvex with beveled edge, film coated tablet with inscription
‘CJ’ on one side and plain on
other side.
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Ciprofloxacin are indicated for the treatment of the following
infections (see sections 4.4 and
5.1). Special attention should be paid to available information on
resistance to ciprofloxacin
before commencing therapy.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
ADULTS:
•
Lower respiratory tract infections due to Gram-negative
bacteria
-
exacerbation of chronic obstructive pulmonary disease. In exacerbat